Survival rates من إعداد فريق مايو كلينك Cancer survival rates tell you the percentage of people who survive a certain type of cancer for a specific amount of time. Cancer statistics often use a five-year relative survival rate. This rate compares survival among people with the cancer and survival among people in the general population. Survival rates can give you a general idea of how people with soft tissue sarcoma have done over time. But they cannot show exactly what will happen for one person. Outlook can be different depending on many factors. For example, the survival rate for soft tissue sarcoma can vary a lot among the many different types. But for soft tissue sarcomas in general, the five-year relative survival rate is about: 83% for cancer that hasn't spread. The cancer has not spread beyond the place it started. This also is called localized cancer. 60% for regional cancer. The cancer has spread nearby to structures or lymph nodes. 17% for distant cancer. The cancer has spread to parts of the body distant from where the cancer started. A common site of distant spread for soft tissue sarcoma is the lungs. Survival rates are based on large groups of people. Your outlook may be different depending on factors such as: Type of soft tissue sarcoma. Tumor size and grade. Whether the cancer has spread. Your age. Your treatment and how well the treatment works. Some soft tissue sarcomas can be cured, especially when the cancer has not spread. Tumors that are smaller and have not spread to other parts of the body often have a better prognosis. Your healthcare team can explain what the survival statistics may mean for your specific situation. Talk with your care team if you want to know more about your prognosis. طلب تحديد موعد التشخيص والعلاج 04/12/2024 تبادلها عبر ارسلها على الفيس بوكارسلها في تغريدة Living with ساركوما الأنسجة الرخوة? Connect with others like you for support and answers to your questions in the Sarcoma support group on Mayo Clinic Connect, a patient community. Sarcoma Discussions FS-DFSP (Fibrosarcomatous dermatofibrosarcoma): Anyone else? 56 Replies Thu, Sep 10, 2026 chevron-right Diagnosed with sarcoma? Let's share 1103 Replies Wed, Sep 09, 2026 chevron-right What treatments did you have for angiosarcoma? 10 Replies Tue, Sep 01, 2026 chevron-right See more discussions إظهار المَراجع Townsend CM Jr, et al. Soft tissue sarcoma. In: Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 21st ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed Feb. 23, 2023. Soft tissue sarcoma. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1464. Accessed Sept. 26, 2022. Goldman L, et al., eds. Malignant tumors of bone, sarcomas, and other soft tissue neoplasms. In: Goldman-Cecil Medicine. 26th ed. Elsevier; 2020. https://www.clinicalkey.com. Accessed Feb. 19, 2023. Goldblum JR, et al., eds. Enzinger and Weiss's Soft Tissue Tumors. 7th ed. https://www.clinicalkey.com. Accessed March 5, 2023. Niederhuber JE, et al., eds. Sarcomas of soft tissue. In: Abeloff's Clinical Oncology. 6th ed. Elsevier; 2020. https://www.clinicalkey.com. Accessed Sept. 26, 2022. Soft tissue sarcoma treatment (PDQ) — Patient version. National Cancer Institute. https://www.cancer.gov/types/soft-tissue-sarcoma/patient/adult-soft-tissue-treatment-pdq. Accessed Feb. 19, 2023. Childhood soft tissue sarcoma treatment (PDQ) — Patient version. National Cancer Institute. https://www.cancer.gov/types/soft-tissue-sarcoma/hp/child-soft-tissue-treatment-pdq. Accessed Feb. 19, 2023. Taking time: Support for people with cancer. National Cancer Institute. https://www.cancer.gov/publications/patient-education/taking-time. Accessed Feb. 19, 2023. Gamboa AC, et al. Soft-tissue sarcoma in adults: An update on the current state of histiotype-specific management in an era of personalized medicine. CA: A Cancer Journal for Clinicians. 2020; doi:10.3322/caac.21605. Ami TR. Allscripts EPSi. Mayo Clinic, Rochester, Minn. April 5, 2023. Sarcoma centers. Sarcoma Alliance. https://sarcomaalliance.org/sarcoma-centers/. Accessed Feb. 17, 2023. SARC clinical trials. Sarcoma Alliance for Research through Collaboration. https://sarctrials.org/research/sarc-clinical-trials/. Accessed Feb. 19, 2023. Salerno KE, et al. Radiation therapy for treatment of soft tissue sarcoma in adults: Executive summary of an ASTRO clinical practice guideline. Practical Radiation Oncology. 2021; doi:10.1016/j.prro.2021.04.005. Brinkmann EJ, et al. Extremity soft tissue sarcoma: Role of local control. Current Treatment Options in Oncology. 2020; doi:10.1007/s11864-020-0703-9. ساركوما الأنسجة الرخوةالأعراضوالأسبابالتشخيصوالعلاجالأطباءوالأقسامالرعاية في MayoClinic(مايو كلينك) CON-20377708 الأمراض والحالات ساركوما الأنسجة الرخوة